On the HCPLive Atopic Dermatitis condition center page, resources on the topics of medical news and expert insight into eczema can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dermatitis research, treatment, and drug development.
May 9th 2024
This analysis was designed to look into the timing and specific elements which mediate the relationship between eczema and systemic antibiotic use.
Probiotics May Prevent Atopic Dermatitis if Microbiome Cooperates
December 13th 2016Previous research showed probiotics given to pregnant women during certain stages of pregnancy and post delivery reduced the likelihood of atopic dermatitis in their children. Recently published reports; however, may not agree.
Atopic Dermatitis Patients Risk Contact Dermatitis from Topical Treatments
December 12th 2016Children with atopic dermatitis (AD) were reported to have a greater risk for developing contact dermatitis from some common ingredients of topical products than those with a history of contact dermatitis but no AD, in a recent comparison of patch testing responses in both groups.
EU Regulators Accept Dupilumab for Review
Regeneron and Sanofi’s highly-anticipated atopic dermatitis drug dupilumab, trade name Dupixent, has been accepted by the European Medicines Agency (EMA) for review. The drug has performed well in trials and is considered an impending blockbuster.
Researchers Examine the Role of Biofilms in Atopic Dermatitis and Psoriasis
“While the concept of biofilms in atopic dermatitis is relatively new, antimicrobial and biofilm dispersing agents have been included in the treatment regimen for atopic dermatitis for decades," according to the study authors.
Which Emollient Makes Atopic Dermatitis Worse?
November 21st 2016Multiple measurements of skin integrity and function were applied to distinguish between the effects of topical emollient products in a recent study. Two popular products in the UK were determined to transiently improve the skin barrier that is thought to be defective in atopic dermatitis (AD), and another product was confirmed to be damaging.
Testing Ustekinumab for Severe Atopic Dermatitis
October 31st 2016Approved by the FDA to treat plaque psoriasis, psoriatic arthritis, and active Crohn's disease, ustekinumab appeared to benefit patients with severe atopic dermatitis (AD) in a small study seeking to correlate its immunologic effects with clinical efficacy.
Reviewing Potential Atopic Dermatitis Treatments and Pathogeneses
A recent review of current research on atopic dermatitis (AD) treatments found that a clearer understanding of the pathogenesis of the phenotypes involved in the disease will lead to advances in new therapies.
New Trials Bolster Dupilumab's “First Line Treatment†Potential for Atopic Dermatitis
Eric Simpson, MD, the lead author on the study, spoke to MD Magazine about the results, which showed great improvement with few side effects for those with moderate or severe atopic dermatitis.
Too Many Ways to Measure an Itch, Derm Study Finds
October 12th 2016Dermatitis researchers use far too many instruments in measuring symptoms of skin ailments, a study found. Symptoms of atopic ezcema/dermatitis (AD) were found in a systematic review of randomized controlled trials (RCTs) to be most often characterized from composite measures rather than stand-alone symptom severity rating instruments, and thirty different instruments were found to have been used across 378 trials.
Early Subcutaneous Allergen Immunotherapy Works for Certain Patients
October 12th 2016Severe atopic dermatitis (AD) symptoms of shorter duration were more likely to improve in allergen sensitized patients receiving desensitizing immunotherapy, than severe symptoms of longer duration or more moderate symptoms, according to a new observational cohort study.
Atopic Dermatitis: Immunotherapy Can Be Effective
October 10th 2016Severe atopic dermatitis (AD) symptoms of shorter duration were more likely to improve in allergen sensitized patients receiving desensitizing immunotherapy, than severe symptoms of longer duration or more moderate symptoms, according to a new observational cohort study.
Which Patients with Atopic Dermatitis Are Least Likely to Outgrow It?
October 6th 2016Childhood atopic dermatitis (AD) usually resolves before adulthood, a meta-analysis of cases showed. Those patients who did see their AD persist were more likely to be female, to have been older at onset, and to have relatively severe AD.
Parent Panic as Leprosy Hits California
A disease that was much-feared but now so rare it is often mistaken for atopic dermatitis, leprosy has been confirmed in a California elementary school pupil. Armadillos are known to harbor and spread the bacteria that cause it.
Assessing Links Between Tobacco Smoke and Atopic Dermatitis
Across the board, researchers saw that studies of active smokers showed increased prevalence of the skin condition, regardless of age or region. It isn't quite clear, though, whether smoking causes AD or AD causes people to smoke.
Crisaborole Ointment: a Novel, Nonsteroidal Atopic Dermatitis Treatment for Children and Adults
In the past 15 years, no new topical AD treatments have been approved. Crisaborole, however, could be an efficient, safe, non-steoidal treatment option, according to the results of two recent phase III studies.